Acupuncture Effect on Digestion in Critically Ill Post-Operative Oral and Hypo-pharyngeal Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 15, 2019

Primary Completion Date

March 19, 2021

Study Completion Date

March 19, 2021

Conditions
Oral CancerHypopharyngeal Cancer
Interventions
OTHER

Specific acupuncture group

"In addition to routine ICU treatments, patients in the specific acupuncture group will also receive daily bilateral traditional Chinese medicine style acupuncture on the following acupuncture points: ST36 (Zu San Li), ST37 (Shangjuxu), ST39 (Xiajuxu), PC6 (Nei Guan) and LI4 (He Gu). The acupoints indications in this group are specific to treat indigestion related conditions. The treatment will take place once a day, over three days, for a total of three treatments. A total of 10 Needles will be used in each session Acupuncture treatment will be performed with sterile needles manufactured by Yu Kuang acupuncture needles 40mm with 30G."

DRUG

Metoclopramide 10mg

Patients in all groups will receive Metoclopramide 10mg/ per 8 hours in the case of poor digestion, alongside the individualized drug treatment prescribed by the ICU medical doctor as per individual patient needs.

OTHER

Non-specific acupuncture group

Patients' in the non-specific acupuncture group (Con-Acu) will receive routine ICU treatment as well as a total of 3 daily non digestion related Traditional Chinese medicine style acupuncture treatments at the following acupoints: LI 15 (Jianyu), SJ 14 (JianLiao) LU3 (Tianfu), GB35 (Yangjiao), BL 59 (Fuyang). The selected control points are not indicated for the treatment of digestion related conditions, and are not reported to improve digestive function.

Trial Locations (1)

40402

surgical and burn intensive care departments and the plastic surgical department of China Medical University Hospital in Taichung city, Taiwan., Taichung

All Listed Sponsors
lead

China Medical University Hospital

OTHER

NCT03934294 - Acupuncture Effect on Digestion in Critically Ill Post-Operative Oral and Hypo-pharyngeal Cancer Patients | Biotech Hunter | Biotech Hunter